Dr Reddys Laboratories Ltd - Share Price
DRREDDY
Dr Reddys Laboratories LtdFinancials
Dr Reddys Laboratories LtdNews & Updates
Nifty Pharma holds steady; Heavyweights Sun Pharma, Dr Reddys, Lupin drive sectoral gains; Biocon un
Jun 23,2021 11:25 AM
Sun Pharma settles patent litigation Celgene over cancer drug.
Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US Market Jun 22,2021
Dr. Reddys launches Icosapent Ethyl Capsules, 1 gram in U.S. Jun 22,2021
Nifty Pharma index steady after bearish start; Cadila, Biocon lift performance Jun 21,2021
Nifty Pharma under selling pressure; Alkem, Torrent Pharma, Lupin weigh down Jun 18,2021
Dr Reddys ordered to pay $46.25 mn to Hatchtech Jun 16,2021
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 664.80 | 71.55 | 159,483.80 | 327.39 | 1.13 | 3,119.04 | 104.36 |
| Divis Laboratories Ltd | 4,250.35 | 57.72 | 112,813.53 | 487.93 | 0.47 | 1,718.39 | 349.25 |
| Dr Reddys Laboratories Ltd | 5,277.65 | 40.16 | 87,807.45 | 311.50 | 0.47 | 3,313.50 | 1,020.99 |
| Cipla Ltd | 950.90 | 31.05 | 76,657.20 | 413.41 | 0.53 | 3,173.39 | 247.09 |
| Cadila Healthcare Ltd | 618.00 | 38.80 | 63,236.58 | 464.70 | 0.57 | 1,949.70 | 124.49 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Dr Reddys Laboratories LtdSummary & Reports
Dr Reddys Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddys offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilar... More
Registered Office
8-2-337 Road No 3,Banjara Hills,Hyderabad, Telangana,500034
Tell. : +91-40-49002900
Website : http://www.drreddys.com
Email : shares@drreddys.com
Registrar Office
3rd Flr 306 Rightwin, Somajiguda, Hyderabad-500082 INDIA
Tell. : +91-40-23374967/23370
Website : www.bigshareonline.com
Email : bsshyd@bigshareonline.com
Reports by dr-reddys-laboratories-ltd-share-price
Latest Release by dr-reddys-laboratories-ltd-share-price
IIFLView
Buy - DRREDDY
Reco. Price
2,521.00
Jun 25, 2021
Target Price
2,891.00
Target Returns:
14.68%
Result Express
Jun 25, 2021 03:11 AM
The company’s consolidated revenue stood at Rs3,858cr, up 3.3% yoy but down 4.3% qoq.
Shareholding Snapshot
Loading ...
| Mar - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 26.74% |
| Total Promoter | 26.74% |
| Non Promoter | - |
| Institutions | 43.93% |
| Non-Institutions | 28.99% |
| Total Non-Promoter | 72.92% |
| Custodian | 0.35% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
14 May 2021
Annc. Date
29 Mar 2021
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Compan... More
Purpose
Board Meeting
Exp. Date
29 Jan 2021
Annc. Date
28 Dec 2020
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Compan... More
Purpose
Board Meeting
Exp. Date
28 Oct 2020
Annc. Date
27 Sep 2020
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Compan... More
